Journal of Biological Chemistry · 1999 · 44 citations · 31 references
Life SciencesMolecular BiologyPharmacologyGene ExpressionInflammationTranscriptional RegulationAnti-inflammatory PharmacologyInflammatory MediatorsInflammatory SignalingLipid MetabolismLipid SignalingNuclear ReceptorsAnti-inflammatory ActivityAnti-inflammatory MechanismsFatty AcidsNuclear Hormone ReceptorsPeroxisome Proliferator-activated Receptor Alpha (Ppar-alpha) SignalingPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated ReceptorsProinflammatory Mediators
Peroxisome proliferator-activated receptor alpha (PPARalpha)is a nuclear receptor for various fatty acids, eicosanoids, and hypolipidemic drugs. In the presence of ligand, this transcription factor increases expression of target genes that are primarily associated with lipid homeostasis. We have previously reported PPARalpha as a nuclear receptor of the inflammatory mediator leukotriene B(4) (LTB(4)) and demonstrated an anti-inflammatory function for PPARalpha in vivo (Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., and Wahli, W. (1996) Nature 384, 39-43). LTB(4) also has a cell surface receptor (BLTR) that mediates proinflammatory events, such as chemotaxis and chemokinesis (Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., and Shimizu, T. (1997) Nature 387, 620-624). In this study, we report on chemical probes that differentially modulate activity of these two LTB(4) receptors. The compounds selected were originally characterized as synthetic BLTR effectors, both agonists and antagonists. Here, we evaluate the compounds as effectors of the three PPAR isotypes (alpha, beta, and gamma) by transient transfection assays and also determine whether the compounds are ligands for these nuclear receptors by coactivator-dependent receptor ligand interaction assay, a semifunctional in vitro assay. Because the compounds are PPARalpha selective, we further analyze their potency in a biological assay for the PPARalpha-mediated activity of lipid accumulation. These chemical probes will prove invaluable in dissecting processes that involve nuclear and cell surface LTB(4) receptors and also aid in drug discovery programs.
31
Steven A. Kliewer, Scott S. Sundseth, Stacey A. Jones et al. · Proceedings of the National Academy of Sciences · 1997 · 2.2K citations · Full text
Olivier Braissant, Fabienne Foufelle, Christian Scotto et al. · Endocrinology · 1996 · 2.1K citations